beijinganbiqidekeyantuandui，tongguozhenghewomenzaikangtiyanfa、gaizaoheshengchanfangmiandejingyan，tuichulezhenduimodanbaibadiandedingzhihuakangtikaifapingtai，weiwomendekehutigongkangmodanbaikangtidekaifayuzhibeifuwu。

modanbaijiyinzhanjiyinzuzhongbianmajiyinde20-30%，tamencanyubutongdeshengwuxueguocheng，baokuopeitishoutidejiehe，xinhaozhuandao，fenziyunshu，xibaojianshibiehemeijiefanying。modanbaizuoweijiyukangtidejibingzhenduanhezhiliaolingyuzhongdeyanfadianxiyinleyuelaiyueduodekexuejiadezhuyi。raner，caiyongchuantongdekangtishengchanjishu，modanbaikangyuandeshengchanmianlinlehenduowenti，rubiaodaliangdi，nanyutiqu，yigoutidechansheng，cuowuzhedie，buwanquanxiushi，gouxiangbianhuadeng。zheixiewentidoushidaozhikangmodanbaikangtishengchanlvdi，jinerzuaimodanbaiyanjiufazhandeyuanyin。

womendemodanbaikangtizhibeipingtaijiangdanbaikangyuanbiaodazaixibao、zhidanbaitihuozheweilitibiaomian，zheixiebiaodafangshiweichilemodanbaidejiegou。liyongcipingtaishengchandekangtishizhenduimodanbaijiegoudekangti，bimianlechuantongfangfashengchanmodanbaidankelongkangtidequedian。tongguoguoqukangtishengchandechenggongjingyanzhengming，zheishiyizhongyouxiaodemodanbaikangtishengchanfangshi。

我司的膜蛋白抗体研发平台包括三种独立的膜蛋白抗原表达方式，可提供满足客户需求的服务：
基于细胞的表达
这种表达方式保留了膜蛋白的抗原表位。
无细胞表达
这种方式来源于一种无细胞表达系统，在体外翻译阶段可以使表达的蛋白直接组装入脂质体（单层或者双层），形成的脂蛋白体可以用于免疫。
病毒样颗粒（VPLS）
zheizhongfangshileisibingdudeziwozuzhuang，shengchandedanbaijingguofanyihouxiushi，tongyangjuyouzhengquedejiegou。cixiangjishukeyijiangjingguofanyihouxiushidemodanbaizuzhuangdaobingduyangkelibiaomian，huodemianyiyuanxing。

beijinganbiqishengwukejiyouxiangongsidemodanbaikangtiyanfapingtaibaokuoliangzhongkangtiyanfajishu，zajiaoliujishuheshijuntizhanshikangtikujishu。womendepingtaiyongyouxiangmudechenggongjingyan，keyiweikehutigongkangmodanbaikangtiyanfafuwu。